Generic drugs top lobbyist to depart by fall
This article was originally published in Scrip
Executive Summary
Ralph Neas, president and CEO of the Generic Pharmaceutical Association (GPhA), said he plans to leave the lobbying group by this fall after serving in the position for four years.